Atorvastatin Impurity, with the CAS number 1357600-18-0, is a chemical compound associated with the pharmaceutical drug atorvastatin, which is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease. This impurity may arise during the synthesis or storage of atorvastatin and can affect the purity and efficacy of the final product. Typically, impurities like this can exhibit characteristics such as varying solubility in different solvents, potential biological activity, and specific spectral properties that can be analyzed using techniques like NMR, HPLC, or mass spectrometry. The presence of impurities is critical to monitor in pharmaceutical formulations, as they can influence the drug's safety, effectiveness, and regulatory compliance. Understanding the chemical structure and behavior of atorvastatin impurities is essential for quality control in drug manufacturing and ensuring patient safety. As with all pharmaceutical substances, proper characterization and quantification are necessary to adhere to regulatory standards and ensure therapeutic efficacy.

Atorvastatin Impurity

1357600-18-0: Atorvastatin Impurity, with the CAS number 1357600-18-0, is a chemical compound associated with the pharmaceutical drug atorvastatin, which is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease. This impurity may arise during the synthesis or storage of atorvastatin and can affect the purity and efficacy of the final product. Typically, impurities like this can exhibit characteristics such as varying solubility in different solvents, potential biological activity, and specific spectral properties that can be analyzed using techniques like NMR, HPLC, or mass spectrometry. The presence of impurities is critical to monitor in pharmaceutical formulations, as they can influence the drug's safety, effectiveness, and regulatory compliance. Understanding the chemical structure and behavior of atorvastatin impurities is essential for quality control in drug manufacturing and ensuring patient safety. As with all pharmaceutical substances, proper characterization and quantification are necessary to adhere to regulatory standards and ensure therapeutic efficacy.

CAS 1357600-18-0

Atorvastatin Impurity

Atorvastatin Impurity 87

Ref: 4Z-A-12127

Atorvastatin Impurity 87

Ref: ST-EA-CP-A32132